socalTECH

JULY 30, 2018

Thousand Oaks-based Amgen has returned as one of the investors in cancer therapeutis developer Sutro Biopharma , as part of an $85.4M funding round. South San Francisco-based Sutro Biopharma said last week that it has raised $85.4M in a Series E funding round.

Thousand Oaks 100

Thousand Oaks Invest Capital Funding 100

socalTECH

APRIL 28, 2014

Thousand Oaks-based wireless hardware provider Xirrus has raised yet another $10M in funding, according to a regulatory filing from the company Monday. The company''s investors include August Capital, Canaan Partners, InterWest, QuestMark Partners, and U.S. xirrus venture capital wireless hardware wifi hotspot'

Thousand Oaks 180

Thousand Oaks Venture Capital Capital Funding 180

socalTECH

JANUARY 9, 2017

Thousand Oaks-based Amgen is the lead investor in a round for San Francisco- and Bozeman, Montana-based SiteOne Therapeutics , SiteOne said on Friday. SiteOne said it raised $15M in a Series B funding round, which was led b Amgen, and also included Next Frontier Capital and insiders.

Thousand Oaks 100

Thousand Oaks Invest Capital Funding 100

socalTECH

NOVEMBER 17, 2017

Amgen Ventures , the venture investment arm of Thousand Oaks-based Amgen , is one of the new investors in precision oncology and medicine startup Syapse.

Thousand Oaks 113

Thousand Oaks Funding Software Capital 113

socalTECH

MARCH 8, 2016

Thousand Oaks-based Amgen has made another investment this morning in immunology startup Tizona Therapeutics , via its venture capital arm, Amgen Ventures. Series A investors--including Amgen Ventures--also participated, with investments from MPM Capital, Astellas Venture Management and InterWest Partners. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Funding Venture Capital Invest 100

socalTECH

DECEMBER 17, 2013

Thousand Oaks-based biopharmaceuticals startup Atara Biotherapeutics announced this morning that it has raised $38.5M The funding came from Amgen Ventures, Celgene Corporation, EcoR1 Capital, plus Alexandria Venture Investments, DAG Ventures, Domain Associates, and Kleiner Perkins Caufield & Byers. READ MORE>>.

Thousand Oaks 180

Thousand Oaks Venture Capital Capital Funding 180

socalTECH

JANUARY 10, 2014

Thousand Oaks-based Atara Biotherapeutics announced this morning that it is in a second close of its Series B funding round, bringing its total raised in the funding to $52M. amgen lifescience disease renal capital venture biotherapeutics atara' READ MORE>>.

Thousand Oaks 147

Thousand Oaks Capital Funding Invest 147

socalTECH

JULY 2, 2014

San Diego-based Ocean Aero , a developer of unmanned, autonomous marine vehicles, has scored funding from Thousand Oaks-based Teledyne , the companies said this morning. investment strategic capital venture marine ocean ship robot autonomous robotic oceanaero aero' Financial terms of the investment were not disclosed.

Thousand Oaks 147

Thousand Oaks Invest San Diego Design 147

socalTECH

JANUARY 5, 2017

the founding shareholder and chairman and treasurer of Thousand Oaks-based Amgen , has died, at the age of 90. Bowes--who also founded venture capital firm USVP --died peacefully in his home on December 28th. Bowes, Jr. , Amgen said that "without Bowes, there would be no Amgen".

Thousand Oaks 113

Thousand Oaks Venture Capital Capital Invest 113

socalTECH

OCTOBER 12, 2016

Thousand Oaks-based Akriveia Therapeutics , a biotechnology startup focused on immuno-oncology, announced this morning that it has raised $7.5M The investment came from F-Prime Capital Partners. in a Series A investment.

Thousand Oaks 100

Thousand Oaks Research Activity Invest 100

socalTECH

DECEMBER 19, 2018

Thousand Oaks-based Amgen and Swiss biotech company Molecular Partners AG said Tuesday that the two are in a collaboration and licensing deal, for the commercialization of a molecule aimed at the immuno-oncology area.

Thousand Oaks 113

Thousand Oaks Design Activity Develop 113

socalTECH

FEBRUARY 21, 2013

Xirrus , the wireless hardware provider based in Thousand Oaks, has just raised $10.1M Xirrus, which is backed by August Capital, Canaan Partners, InterWest Partners, QuestMark Partners, and US Venture Partners, last announced a funding round back in September. in a funding round, part of an ongoing $11.0M

Thousand Oaks 164

Thousand Oaks Conference Networking Capital 164

socalTECH

OCTOBER 23, 2015

Thousand Oaks-based SunBrite TV , a manufacturer of large screen, HDTV screens specifically designed to be installed outdoors, next to pools, on patios, and elsewhere, has been acquired by SnapAV , which is owned by private equity investor General Atlantic. SunBriteTV was backed by Bunker Hill Capital. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Screening Equity Acquisition 100

socalTECH

OCTOBER 9, 2015

Thousand Oaks-based Amgen has seen an exit out of its startup investment portfolio, and activities of its Amgen Ventures venture capital arm, at Berkeley-based Adheron Therapeutics this morning. Adheron said that it has been acquired by Roche , in a deal worth $105M upfront and up to $475M in additional milestone payments.

Thousand Oaks 100

Thousand Oaks Venture Capital Activity Capital 100

socalTECH

JANUARY 7, 2016

Thousand Oaks-based biotech giant Amgen is the a new investor in a round for Alector , a developer of immuno-modulatory therapies for Alzheimer's disease and other neurogenerative disorders, which announced a $29.5M funding today. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Google Research Funding 100

socalTECH

APRIL 20, 2017

Thousand Oaks-based wireless networking equipment maker Xirrus has been acquired by Riverbed , to help bolster its SD WAN efforts, the two said on Wednesday. Financial terms of the acquisition were not announced. Riverbed said it will continue to offer up Xirrus as a stand-alone enterprise WLAN solution.

Thousand Oaks 127

Thousand Oaks Acquisition Startup Networking 127

socalTECH

APRIL 10, 2012

Thousand Oaks-based biotech giant Amgen said this morning that it has agreed to buy KAI Pharmaceuticals , a developer of treatments for secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) who are on dialysis, for $315M in cash. KAI Pharmaceuticals is based in South San Francisco. READ MORE>>.

Thousand Oaks 160

Thousand Oaks Capital Develop Development 160

socalTECH

SEPTEMBER 8, 2011

Thousand Oaks-based biotech giant Amgen has backed a developer of therapeutic antibodies, via its venture capital arm, Amgen Ventures. Other investors in the round were ARCH Venture Partners, Canaan Partners, MPM Capital, Healthcare Ventures, Alexandria Real Estate Equities, and Zenyaku Kogyo. READ MORE>>.

Thousand Oaks 150

Thousand Oaks Venture Capital Equity Capital 150

socalTECH

NOVEMBER 7, 2013

Thousand Oaks-based ImmunGene , a startup biotech company developing antibody-based, protein therapeutics for treating cancer, said today that it has raised $9M in a Series A funding, to advance its early stage development products. immungene venture capital biotech biotechnology cancer therapeutics' READ MORE>>.

Thousand Oaks 164

Thousand Oaks UCLA Venture Capital Equity 164

socalTECH

OCTOBER 5, 2015

Thousand Oaks-based Teledyne Technologies said this morning that it is cutting its outlook for the third quarter and full year, due to decline in sales in energy-related products. dollar and "challenging" capital spending environment impacting its results. The company also blamed a strong U.S. READ MORE>>.

Sales 100

Sales Thousand Oaks Marketing Technical Review 100

socalTECH

APRIL 24, 2012

Amgen Ventures , the venture capital arm of Thousand Oaks-based Amgen , has re-upped on an investment in a biopharmaceuticals developing microRNA-based treatments for cardiovascular and muscle disease. and Broadview Ventures. miRagen is based in Boulder, Colorado.

Thousand Oaks 150

Thousand Oaks Venture Capital Invest Capital 150

socalTECH

APRIL 24, 2012

George Rathmann , the founding CEO of Thousand Oaks biotech giant Amgen , has died, the company announced late Monday evening. Rathman helped secure Amgen's venture capital funding and guide Amgen to its IPO, as well as growing the company to one of the largest biotech firms in the world.

Thousand Oaks 150

Thousand Oaks Guide Venture Capital Capital 150

socalTECH

JULY 9, 2012

Thousand Oaks-based wireless equipment maker Xirrus appears to have raised $18.4M According to the filing, representatives of US Venture Partners, August Capital, Alta Partners, and Canaan Partners all have board seats. more in a funding round, part of an ongoing $25.3M funding, according to a regulatory filing by the company.

Thousand Oaks 140

Thousand Oaks Funding Capital Company 140

socalTECH

SEPTEMBER 26, 2012

Thousand Oaks-based Xirrus , the developer of high speed, high performance wireless networking hardware, has raised another big chunk of financing, saying today that it has raised $23.5M in a Series E funding round.

Networking 153

Networking Thousand Oaks Sales Capital 153

socalTECH

MAY 8, 2012

The venture capital arm of Thousand Oaks-based Amgen has placed more funding into one of its portfolio companies, Sutro Biopharma , which is working on developing a scalable biochemical protein synthesis platform aimed at cancer therapeutics. Sutro said it has raised $16.5M

Thousand Oaks 140

Thousand Oaks Invest Venture Capital Platform 140

socalTECH

APRIL 8, 2014

Thousand Oaks-based drug development company Atara Biotherapeutics announced this morning that it has added Matthew K. Fust as a board member, and hired Mitchall G. Clark as its Chief Regulatory and Quality Assurance Officer. READ MORE>>. atara biotherapeutics renal disease lifescience amgen executive board'

Thousand Oaks 138

Thousand Oaks Invest Capital Funding 138

socalTECH

AUGUST 13, 2013

Wilcon said its network now connects Los Angeles, Burbank, Pasadena, Santa Monica, Woodland Hills, Thousand Oaks, Santa Clarita, Long Beach, Irvine, Riverside, Carlsbad and San Diego. Wilcon said it was supported in the deal by Pamlico Capital; financial details of that backing was also not announced. READ MORE>>.

Santa Clarita 147

Santa Clarita Woodland Hills Networking Thousand Oaks 147

socalTECH

JANUARY 24, 2011

Thousand Oaks-based biotech giant Amgen said Monday afternoon that it is acquiring Biovex , a Woburn, Massachusetts-based developer of treatments for melanoma and head and neck cancer. BioVex develops OncoVEX, a novel oncolytic vaccine in Phase 3 clinical development. READ MORE>>.

Thousand Oaks 167

Thousand Oaks Sales Invest Capital 167

socalTECH

JANUARY 3, 2013

YouMail is led by Alex Quilici, and backed by VantagePoint Capital Partners, the Tech Coast Angels, the Tech Coast Angels ACE Fund, Siemer Ventures, and the CrunchFund. Red Pocket Mobile is based in Thousand Oaks. The two said that Red Pocket Mobile's customers can now access YouMail from any compatible GSM phone.

Tech Coast Angels 138

Tech Coast Angels Thousand Oaks Mobile Services 138

socalTECH

AUGUST 31, 2011

Amgen Ventures , the venture capital arm of Thousand Oaks-based Amgen , has backed the developer of a biopharmaceutical aimed at treating irritable bowel syndrome, kidney disease, and diabetes.

Thousand Oaks 150

Thousand Oaks Venture Capital Capital Funding 150

socalTECH

MAY 6, 2016

Thousand Oaks-based Amgen has helped to back a new, life sciences fund, managed by San Francisco-based venBio , as an anchor supporter of a new fund. venBio did not say how much Amgen committed to the fund, which is venBio's second life sciences fund.

Thousand Oaks 100

Thousand Oaks Funding Help Technology 100

socalTECH

FEBRUARY 28, 2012

Thousand Oaks-based Ceres , the developer of seed stock for energy crops, said today that it has closed its IPO, selling a total of 5,750,000 shares of its common stock at $13.00 Barclays Capital, Piper Jaffray, Raymond James, and Simmons & Company International. The firm's IPO was underwritten by Goldman Scahs & Co.,

Thousand Oaks 140

Thousand Oaks Southern California Marketing Capital 140

socalTECH

JULY 2, 2010

Thousand Oaks-based Ceres , a developer of biofuel crop technology, has raised another $20M in funding, according to a regulatory filing from the firm Friday. Tags: warburg capital venture clean cleantech energy biofuel ceres. Source of the new funding was not disclosed. The filing indicates the round came from five investors.

Thousand Oaks 150

Thousand Oaks Equity Funding Capital 150

socalTECH

JULY 6, 2015

Thousand Oaks-based Teledyne Technologies has increased its stake in San Diego-based Ocean Aero , a developer of unmanned, robotic underwater and surface vehicles used for the scientific, defense, and oil and gas market, the company said late Friday. Financial terms of the deal were not disclosed.

Thousand Oaks 100

Thousand Oaks San Diego Invest Marketing 100

socalTECH

JANUARY 25, 2012

Thousand Oaks-based Ceres , the developer of seeds to supply the bioenergy and biofuels feedstock business, has set its initial pricing range for its IPO, according to a filing from the company this morning. Barclays Capital, Piper Jaffray, Raymond James, and Simmons & Company International. and $23.00

Pricing 145

Pricing Thousand Oaks Design Capital 145

socalTECH

MAY 23, 2011

Thousand Oaks-based Ceres , the developer of seeds aimed at producing renewable, biomass feedstocks for the biofuels industry, has filed for an IPO. and Barclays Capital. and Barclays Capital. The firm's IPO is being underwritten by Goldman, Sachs & co., The firm's IPO is being underwritten by Goldman, Sachs & co.,

Thousand Oaks 140

Thousand Oaks .Net Capital Marketing 140

socalTECH

FEBRUARY 22, 2012

Thousand Oaks-based Ceres , the developer of specialized seeds for the biofuels market, has priced its IPO, saying that it will offer up 5,000,000 shares of its common stock at $13.00 Barclays Capital, PIper Jaffray, Raymond James, and Simmons & Company International. The IPO was underwritten by Goldman, Sachs & CO.,

Pricing 150

Pricing Thousand Oaks Startup Design 150